Quarter Financials
Arrowhead Pharmaceuticals, Inc. (ARWR)
$47.02
+1.06 (+2.31%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Net Income | -72 | 44 | -63 | -63 | -30 | -27 | -21 | -48 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -735 | -663 | -708 | -645 | -581 | -551 | -525 | -504 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Capital Expenditure | -10 | -5 | -6 | -8 | -4 | -7 | -4 | -2 |
|---|
| Net PPE | 141 | 71 | 69 | 66 | 66 | 58 | 49 | 47 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| New Purchases | -85 | - | -40 | -55 | -146 | -66 | -83 | -75 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|